M A Holscher
Overview
Explore the profile of M A Holscher including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
306
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xu C, Holscher M, Jones M, Singh P
J Toxicol Environ Health
. 1995 Jul;
45(3):261-77.
PMID: 7609002
The ability of monoisoamyl meso-2,3-dimercaptosuccinate (Mi-ADMS) to offset the characteristic organ pathology of intraperitoneally administered cadmium chloride (CdCl2) and that of the cadmium-cysteine complex has been examined in male Wistar...
2.
Jones M, Basinger M, Holscher M, Singh P
Fundam Appl Toxicol
. 1992 Oct;
19(3):432-7.
PMID: 1334016
The effects of two dithiocarbamates (both of which induce an increase in the excretion of cadmium) on the biliary and urinary excretion of the essential trace elements zinc, copper, iron,...
3.
Jones M, Basinger M, Holscher M
Fundam Appl Toxicol
. 1992 Feb;
18(2):181-8.
PMID: 1601218
Several clinically used sulfur-containing compounds were examined as potential antagonists for the nephrotoxicity of cis-platin in Sprague-Dawley rats. The compounds studied were biotin, captopril, cefoxitin, cephalexin, the sodium salt of...
4.
Jones M, Basinger M, Field L, Holscher M
Anticancer Res
. 1991 Sep;
11(5):1939-42.
PMID: 1768065
The administration of dimethyl sulfoxide with cisplatin at a mole ratio of 200:1 results in a considerable reduction in the nephrotoxicity produced when cisplatin alone is administered to Sprague-Dawley rats...
5.
Jones M, Singh P, Jones S, Holscher M
Pharmacol Toxicol
. 1991 Feb;
68(2):115-20.
PMID: 1852716
The preparation and properties of two novel cadmium-mobilizing dithiocarbamates namely, sodium N-(4-methylbenzyl)-and sodium N-(4-methoxybenzyl)-4-O-(beta-D-galactopyranosyl)-D-glucamine-N-carbo dithioates derived from alpha-lactose and substituted benzylamines are described. These compounds are more effective than previously...
6.
Jones M, Basinger M, Holscher M
Anticancer Res
. 1991 Jan;
11(1):449-53.
PMID: 2018382
Six compounds containing a thioether group were examined as agents for the reduction of the nephrotoxicity caused by cisplatin (CDDP) in the rat. Of these, five were able to reduce...
7.
Jones M, Basinger M, Holscher M
Toxicology
. 1991 Jan;
68(3):227-47.
PMID: 1896997
Several procedures which have been reported as effective for the control of cisplatin induced nephrotoxicity were compared in the Sprague-Dawley rat using the same dose of cisplatin. The treatments examined...
8.
Jones M, Basinger M, Beaty J, Holscher M
Cancer Chemother Pharmacol
. 1991 Jan;
29(1):29-32.
PMID: 1742846
An examination of the comparative nephrotoxicity in the rat of cisplatin, its hydrolysis product (mostly cis-[Pt(NH3)2Cl(H2O)]+ under the conditions applied), and cis-[Pt(NH3)2(guanosine)2]2+ revealed that these compounds differed significantly in the...
9.
Wilson R, Holscher M, Chang T, Hodges J
J Vet Diagn Invest
. 1990 Jul;
2(3):242-4.
PMID: 1965586
No abstract available.
10.
Basinger M, Jones M, Holscher M
Fundam Appl Toxicol
. 1990 Apr;
14(3):568-77.
PMID: 2340984
The pathological changes characteristically observed in the kidney, bone marrow, thymus, spleen, and duodenum of the rat given 12.2 mg/kg of cis-platinum (CDDP) ip are reduced or eliminated when a...